MCMedicalCodingSoftware
Free trial
XW0DXM6

XW0DXM6 — Introduction of Baricitinib into Mouth and Pharynx, External Approach, New Technology Group 6

Billable / specific codeICD-10-PCS

CMS abbreviated title: Introduce Baricitinib in Mouth/Phar, Extern, New Tech 6

How XW0DXM6 is built

Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.

  1. XSectionNew Technology — What family of procedure this is
  2. WBody systemWhich system it acts on
  3. 0Root operationThe objective — the verb of the procedure
  4. DBody partThe specific site
  5. XApproachHow the site was reached
  6. MDeviceWhat was left in place, if anything
  7. 6QualifierA further distinction where one applies

Codes near XW0DXM6

In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.

  • XW043W5Introduction of Caplacizumab into Central Vein, Percutaneous Approach, New Technology Group 5
  • XW043WBIntroduction of Fosfomycin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 11
  • XW053T9Introduction of Melphalan Hydrochloride Antineoplastic into Peripheral Artery, Percutaneous Approach, New Technology Group 9
  • XW0DX38Introduction of Maribavir Anti-infective into Mouth and Pharynx, External Approach, New Technology Group 8
  • XW0DX82Introduction of Uridine Triacetate into Mouth and Pharynx, External Approach, New Technology Group 2
  • XW0DXF5Introduction of Other New Technology Therapeutic Substance into Mouth and Pharynx, External Approach, New Technology Group 5
  • XW0DXJ9Introduction of Quizartinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 9
  • XW0DXK8Introduction of Sabizabulin into Mouth and Pharynx, External Approach, New Technology Group 8
  • XW0DXM6Introduction of Baricitinib into Mouth and Pharynx, External Approach, New Technology Group 6
  • XW0DXN9Introduction of SER-109 into Mouth and Pharynx, External Approach, New Technology Group 9
  • XW0DXR7Introduction of Fostamatinib into Mouth and Pharynx, External Approach, New Technology Group 7
  • XW0DXVBIntroduction of Xanomeline and Trospium Chloride into Mouth and Pharynx, External Approach, New Technology Group 11
  • XW0G738Introduction of Maribavir Anti-infective into Upper GI, Via Natural or Artificial Opening, New Technology Group 8
  • XW0G7K8Introduction of Sabizabulin into Upper GI, Via Natural or Artificial Opening, New Technology Group 8
  • XW0G7M6Introduction of Baricitinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 6
  • XW0G7R7Introduction of Fostamatinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 7
  • XW0G886Introduction of Mineral-based Topical Hemostatic Agent into Upper GI, Via Natural or Artificial Opening Endoscopic, New Technology Group 6
ICD-10-PCSFY2026